However, new tumor events occurred significantly more frequently in ACC subjects with low (68%) compared to high (29%) (p = 0.0101) or medium and high (38%) (p = 0.0156) expression of PD-L1. This evidence concerns the gene CD274 and adrenal cortex carcinoma.